company background image
605077 logo

Zhejiang Huakang Pharmaceutical SHSE:605077 Stock Report

Last Price

CN¥16.01

Market Cap

CN¥4.8b

7D

2.6%

1Y

-8.6%

Updated

19 Nov, 2024

Data

Company Financials +

Zhejiang Huakang Pharmaceutical Co., Ltd.

SHSE:605077 Stock Report

Market Cap: CN¥4.8b

Zhejiang Huakang Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhejiang Huakang Pharmaceutical
Historical stock prices
Current Share PriceCN¥16.01
52 Week HighCN¥20.12
52 Week LowCN¥11.85
Beta0.63
11 Month Change13.14%
3 Month Change25.08%
1 Year Change-8.55%
33 Year Change-33.78%
5 Year Changen/a
Change since IPO-45.13%

Recent News & Updates

Zhejiang Huakang Pharmaceutical's (SHSE:605077) Anemic Earnings Might Be Worse Than You Think

Nov 02
Zhejiang Huakang Pharmaceutical's (SHSE:605077) Anemic Earnings Might Be Worse Than You Think

Zhejiang Huakang Pharmaceutical Co., Ltd.'s (SHSE:605077) Earnings Are Not Doing Enough For Some Investors

Oct 14
Zhejiang Huakang Pharmaceutical Co., Ltd.'s (SHSE:605077) Earnings Are Not Doing Enough For Some Investors

Zhejiang Huakang Pharmaceutical (SHSE:605077) Will Want To Turn Around Its Return Trends

Sep 26
Zhejiang Huakang Pharmaceutical (SHSE:605077) Will Want To Turn Around Its Return Trends

Recent updates

Zhejiang Huakang Pharmaceutical's (SHSE:605077) Anemic Earnings Might Be Worse Than You Think

Nov 02
Zhejiang Huakang Pharmaceutical's (SHSE:605077) Anemic Earnings Might Be Worse Than You Think

Zhejiang Huakang Pharmaceutical Co., Ltd.'s (SHSE:605077) Earnings Are Not Doing Enough For Some Investors

Oct 14
Zhejiang Huakang Pharmaceutical Co., Ltd.'s (SHSE:605077) Earnings Are Not Doing Enough For Some Investors

Zhejiang Huakang Pharmaceutical (SHSE:605077) Will Want To Turn Around Its Return Trends

Sep 26
Zhejiang Huakang Pharmaceutical (SHSE:605077) Will Want To Turn Around Its Return Trends

Improved Earnings Required Before Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077) Shares Find Their Feet

Jul 02
Improved Earnings Required Before Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077) Shares Find Their Feet

Zhejiang Huakang Pharmaceutical (SHSE:605077) May Have Issues Allocating Its Capital

May 28
Zhejiang Huakang Pharmaceutical (SHSE:605077) May Have Issues Allocating Its Capital

We Think That There Are Some Issues For Zhejiang Huakang Pharmaceutical (SHSE:605077) Beyond Its Promising Earnings

May 02
We Think That There Are Some Issues For Zhejiang Huakang Pharmaceutical (SHSE:605077) Beyond Its Promising Earnings

Shareholder Returns

605077CN FoodCN Market
7D2.6%-5.8%-6.7%
1Y-8.6%-3.9%1.9%

Return vs Industry: 605077 underperformed the CN Food industry which returned -3.9% over the past year.

Return vs Market: 605077 underperformed the CN Market which returned 1.9% over the past year.

Price Volatility

Is 605077's price volatile compared to industry and market?
605077 volatility
605077 Average Weekly Movement8.0%
Food Industry Average Movement6.8%
Market Average Movement8.2%
10% most volatile stocks in CN Market12.5%
10% least volatile stocks in CN Market5.5%

Stable Share Price: 605077 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 605077's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20011,350Deshui Chenwww.huakangpharma.com

Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols and starch sugar worldwide. It offers xylitol, a polyol with close to sugar sweetness; sorbitol, a sugar alcohol white crystal powder or colorless liquid; maltitol, a sugar alcohol; xylose that is used in xylitol production; and L-arabinos, which can be used as sucrose replacement or additives. The company was founded in 2001 and is based in Quzhou, China.

Zhejiang Huakang Pharmaceutical Co., Ltd. Fundamentals Summary

How do Zhejiang Huakang Pharmaceutical's earnings and revenue compare to its market cap?
605077 fundamental statistics
Market capCN¥4.77b
Earnings (TTM)CN¥283.61m
Revenue (TTM)CN¥2.85b

16.8x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
605077 income statement (TTM)
RevenueCN¥2.85b
Cost of RevenueCN¥2.23b
Gross ProfitCN¥617.71m
Other ExpensesCN¥334.10m
EarningsCN¥283.61m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.95
Gross Margin21.70%
Net Profit Margin9.96%
Debt/Equity Ratio66.1%

How did 605077 perform over the long term?

See historical performance and comparison

Dividends

3.4%

Current Dividend Yield

56%

Payout Ratio